The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy-Reference-Cited by-同舟云学术

The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy

Published:2017-05 Issue:5 Volume:35 Page:183-191
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Crawford E. David,Schally Andrew V.,Pinthus Jehonathan H.,Block Norman L.,Rick Ferenc G.,Garnick Marc B.,Eckel Robert H.,Keane Thomas E.,Shore Neal D.,Dahdal David N.,Beveridge Thomas J.R.,Marshall Dennis C.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference99 articles.

1. De novo biosynthesis of FSH like peptide by the human prostate;Hurkadli;Life Sci,1990

2. Immunocytochemical localisation of follicle stimulating hormone (FSH) in normal, benign and malignant human prostates;Hurkadli;Br J Cancer,1990

3. Immunocytochemical localization of follicle stimulating hormone in normal human stomach;Mandrekar;Anat Rec,1990

4. Prostate—an extrapituitary source of follicle-stimulating hormone (FSH): occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents;Garde;Prostate,1991

5. Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR);Ben-Josef;J Urol,1999

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer;Urologic Oncology: Seminars and Original Investigations;2024-07

2. A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk;Clinical Pharmacology in Drug Development;2024-05-17

3. FSH, bone, belly and brain;Journal of Endocrinology;2024-04-03

4. FSH Is Responsible for Androgen Deprivation Therapy–Associated Atherosclerosis in Mice by Exaggerating Endothelial Inflammation and Monocyte Adhesion;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-03

5. Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology;Cancer Innovation;2024-02-05